Compare Bristol-Myers Squibb Co (BMY) vs Advanced Drainage Systems Inc (WMS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bristol-Myers Squibb Co vs Advanced Drainage Systems Inc — how do they compare? Bristol-Myers Squibb Co trades at $63.93 (market cap $129.94B), while Advanced Drainage Systems Inc trades at $139.1 (market cap $10.83B). The key difference: Bristol-Myers Squibb Co is far larger — about 12× Advanced Drainage Systems Inc's market cap, and Bristol-Myers Squibb Co pays the higher dividend (3.96%). Which is the better fit depends on your goals.
| BMY | WMS | |
|---|---|---|
Market Cap | $129.94B | $10.83B |
Sector | Health | Industrials |
52-Week High | $65.89 | $175.38 |
52-Week Low | $42.60 | $129.50 |
Enterprise Value | $163.92B | $12.44B |
Dividend Yield | 3.96% | 0.56% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bristol Myers Squibb (BMY) trades at $64.84, up 0.19% today, with a bullish technical signal from moving averages and strong fundamental health evidenced by a 14.01 P/E ratio and 18.87% net income margin. Recent earnings beats and a $2.3 billion manufacturing investment in Houston highlight operational strength, while analyst consensus is mixed with a $68.56 price target.
The outlook is positive due to earnings momentum and strategic investments, but risks include patent expirations and high debt levels. Wall Street sentiment is cautiously optimistic, with institutional buying supporting the stock's potential for moderate upside from current levels.
Advanced Drainage Systems (WMS) trades at $141.67, down 1.58% with bearish technical signals. The company demonstrates strong profitability with 14% net margins and consistent earnings beats, though revenue growth has moderated. Recent Q1 2027 results showed 21% sales growth to $1 billion, beating expectations. Technical indicators show resistance at $143 with support at $140, while moving averages signal bearish momentum.
WMS offers solid fundamentals with attractive upside to the $185.86 consensus target, but faces near-term technical headwinds. The company's water management solutions benefit from infrastructure spending, though competitive pressures and margin compression present risks. Analyst sentiment is mixed with 41% buy ratings, suggesting cautious optimism for long-term investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bristol-Myers Squibb Co
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →About Advanced Drainage Systems Inc
Advanced Drainage Systems Inc is engaged in designing, manufacturing, and marketing thermoplastic corrugated pipe and related water management products in North and South America, and Europe. The company's operating segment includes Pipe
Read more on WMS →
